Ori Biotech a cell and gene therapy (CGT) manufacturing technology producer located within CIC Philadelphia, recently announced the commercial launch of IRO, a next-generation platform.

Manufacturing remains a critical barrier to scaling CGTs, limiting the clinical and commercial impact of this life-saving new class of therapies. Ori Biotech has developed the IRO platform as part of its mission to enable widespread patient access to life-saving CGTs.

Read more